1. Home
  2. AVNW vs ALLO Comparison

AVNW vs ALLO Comparison

Compare AVNW & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNW
  • ALLO
  • Stock Information
  • Founded
  • AVNW 2006
  • ALLO 2017
  • Country
  • AVNW United States
  • ALLO United States
  • Employees
  • AVNW N/A
  • ALLO N/A
  • Industry
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AVNW Technology
  • ALLO Health Care
  • Exchange
  • AVNW Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • AVNW 274.4M
  • ALLO 252.9M
  • IPO Year
  • AVNW 2007
  • ALLO 2018
  • Fundamental
  • Price
  • AVNW $23.48
  • ALLO $1.13
  • Analyst Decision
  • AVNW Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • AVNW 4
  • ALLO 10
  • Target Price
  • AVNW $36.50
  • ALLO $8.88
  • AVG Volume (30 Days)
  • AVNW 126.2K
  • ALLO 3.0M
  • Earning Date
  • AVNW 09-10-2025
  • ALLO 11-06-2025
  • Dividend Yield
  • AVNW N/A
  • ALLO N/A
  • EPS Growth
  • AVNW N/A
  • ALLO N/A
  • EPS
  • AVNW 0.10
  • ALLO N/A
  • Revenue
  • AVNW $434,606,000.00
  • ALLO N/A
  • Revenue This Year
  • AVNW $6.43
  • ALLO N/A
  • Revenue Next Year
  • AVNW $7.33
  • ALLO $100.00
  • P/E Ratio
  • AVNW $240.25
  • ALLO N/A
  • Revenue Growth
  • AVNW 6.50
  • ALLO N/A
  • 52 Week Low
  • AVNW $12.96
  • ALLO $0.86
  • 52 Week High
  • AVNW $26.83
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • AVNW 53.41
  • ALLO 47.86
  • Support Level
  • AVNW $22.07
  • ALLO $1.09
  • Resistance Level
  • AVNW $24.55
  • ALLO $1.21
  • Average True Range (ATR)
  • AVNW 1.11
  • ALLO 0.07
  • MACD
  • AVNW 0.13
  • ALLO 0.01
  • Stochastic Oscillator
  • AVNW 40.43
  • ALLO 33.33

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: